Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001415889-24-019339

President and CEO bought 35,000 shares at $2.11 ($73,850)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brady Stephen R President and CEO 2024-07-03 Purchase +35,000 $2.11 $73,850 46,376 D
Open-market purchases · 35,000 sh · avg $2.11 · $73,850
Loading xslF345X05/form4-07082024_040701.xml…